269 related articles for article (PubMed ID: 30251696)
1. Crosstalk between Na
Fujii T; Shimizu T; Yamamoto S; Funayama K; Fujita K; Tabuchi Y; Ikari A; Takeshima H; Sakai H
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3792-3804. PubMed ID: 30251696
[TBL] [Abstract][Full Text] [Related]
2. [Cancer cell-specific functional relation between Na
Fujii T; Shimizu T; Takeshima H; Sakai H
Nihon Yakurigaku Zasshi; 2019; 154(3):103-107. PubMed ID: 31527358
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gastric H+,K+-ATPase by 4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), an inhibitor of volume-regulated anion channel.
Fujii T; Takahashi Y; Takeshima H; Saitoh C; Shimizu T; Takeguchi N; Sakai H
Eur J Pharmacol; 2015 Oct; 765():34-41. PubMed ID: 26277321
[TBL] [Abstract][Full Text] [Related]
4. [Novel pathophysiological functions of Na
Fujii T; Shimizu T; Sakai H
Nihon Yakurigaku Zasshi; 2023; 158(6):465-468. PubMed ID: 37914325
[TBL] [Abstract][Full Text] [Related]
5. LRRC8A channels support TNFα-induced superoxide production by Nox1 which is required for receptor endocytosis.
Choi H; Ettinger N; Rohrbough J; Dikalova A; Nguyen HN; Lamb FS
Free Radic Biol Med; 2016 Dec; 101():413-423. PubMed ID: 27838438
[TBL] [Abstract][Full Text] [Related]
6. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
7. The LRRC8 volume-regulated anion channel inhibitor, DCPIB, inhibits mitochondrial respiration independently of the channel.
Afzal A; Figueroa EE; Kharade SV; Bittman K; Matlock BK; Flaherty DK; Denton JS
Physiol Rep; 2019 Dec; 7(23):e14303. PubMed ID: 31814333
[TBL] [Abstract][Full Text] [Related]
8. Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells.
Yoshimoto S; Matsuda M; Kato K; Jimi E; Takeuchi H; Nakano S; Kajioka S; Matsuzaki E; Hirofuji T; Inoue R; Hirata M; Morita H
Eur J Pharmacol; 2021 Mar; 895():173881. PubMed ID: 33476655
[TBL] [Abstract][Full Text] [Related]
9. [Different Membrane Environments Generate Multiple Functions of P-type Ion Pumps].
Fujii T
Yakugaku Zasshi; 2021; 141(11):1217-1222. PubMed ID: 34719540
[TBL] [Abstract][Full Text] [Related]
10. The Volume-Regulated Anion Channel LRRC8/VRAC Is Dispensable for Cell Proliferation and Migration.
Liu T; Stauber T
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151189
[TBL] [Abstract][Full Text] [Related]
11. Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular Na
Fujii T; Katoh M; Ootsubo M; Nguyen OTT; Iguchi M; Shimizu T; Tabuchi Y; Shimizu Y; Takeshima H; Sakai H
J Cell Physiol; 2022 Jul; 237(7):2980-2991. PubMed ID: 35511727
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting.
Xu ZW; Wang FM; Gao MJ; Chen XY; Hu WL; Xu RC
Biol Pharm Bull; 2010; 33(5):743-51. PubMed ID: 20460749
[TBL] [Abstract][Full Text] [Related]
13. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
Wang Y; Qiu Q; Shen JJ; Li DD; Jiang XJ; Si SY; Shao RG; Wang Z
Int J Biochem Cell Biol; 2012 Nov; 44(11):1813-24. PubMed ID: 22750415
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
15. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Apolipoprotein E Enhanced Sensitivity of Hep3B Cells to Cardiac Steroids via Regulating Na+/K+-ATPase Signalosome.
Liu M; Feng LX; Sun P; Liu W; Mi T; Lei M; Wu W; Jiang B; Yang M; Hu L; Guo DA; Liu X
Mol Cancer Ther; 2016 Dec; 15(12):2955-2965. PubMed ID: 27507851
[TBL] [Abstract][Full Text] [Related]
18. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
Schoner W; Scheiner-Bobis G
Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
[TBL] [Abstract][Full Text] [Related]
19. Na+/K+-ATPase α1 isoform mediates ouabain-induced expression of cyclin D1 and proliferation of rat sertoli cells.
Lucas TF; Amaral LS; Porto CS; Quintas LE
Reproduction; 2012 Dec; 144(6):737-45. PubMed ID: 23028124
[TBL] [Abstract][Full Text] [Related]
20. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.
Dostanic-Larson I; Van Huysse JW; Lorenz JN; Lingrel JB
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15845-50. PubMed ID: 16243970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
